Publication
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, random...
Hypolite Muhindo Mavoko, Carolyn Nabasumba, Raquel Inocêncio da Luz, Halidou Tinto, Umberto D'Alessandro, Andrew Kambugu, Vito Baraka, Anna Rosanas-Urgell, Pascal Lutumba, Jean-Pierre Van geertruyden
The Lancet Global Health, January 2017, Elsevier
DOI: 10.1016/s2214-109x(16)30236-4